Healthpeak Properties, Inc. (NYSE:DOC) Receives Consensus Rating of “Moderate Buy” from Brokerages

Healthpeak Properties, Inc. (NYSE:DOC) has earned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $22.62.

A number of equities research analysts have commented on the company. Wedbush raised their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Monday, July 29th. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday. Scotiabank lifted their price target on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a report on Monday, September 9th. Citigroup lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, Wells Fargo & Company reiterated an “equal weight” rating and set a $23.00 price target (up from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st.

Healthpeak Properties Trading Down 0.3 %

NYSE:DOC opened at $22.53 on Wednesday. Healthpeak Properties has a 1-year low of $15.24 and a 1-year high of $23.26. The firm has a market capitalization of $15.85 billion, a price-to-earnings ratio of 64.36, a price-to-earnings-growth ratio of 3.30 and a beta of 1.14. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.91. The stock has a fifty day simple moving average of $22.27 and a 200 day simple moving average of $20.71.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The business had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. During the same quarter in the previous year, the business posted $0.45 earnings per share. The company’s revenue was up 25.9% compared to the same quarter last year. Sell-side analysts forecast that Healthpeak Properties will post 1.79 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.33%. The ex-dividend date of this dividend is Monday, November 4th. Healthpeak Properties’s payout ratio is 342.86%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in DOC. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Healthpeak Properties in the 2nd quarter valued at approximately $66,000. Point72 DIFC Ltd bought a new position in Healthpeak Properties in the 2nd quarter worth approximately $161,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Healthpeak Properties in the 2nd quarter worth approximately $9,024,000. Centaurus Financial Inc. bought a new position in Healthpeak Properties in the 2nd quarter worth approximately $227,000. Finally, Massmutual Trust Co. FSB ADV bought a new position in Healthpeak Properties in the 3rd quarter worth approximately $108,000. 93.57% of the stock is owned by institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.